In a joint project led by Dr. Ehud Cohen and his team at the Institute for Medical Research Israel-Canada (IMRIC) and startup company TyrNovo, a novel compound was found to selectively inhibit the aging process without affecting lifespan — thereby, holding promise for the development of drugs for diseases like Alzheimer's, Parkinson's and Huntington's.
Hebrew University President Menahem Ben-Sasson signed a research agreement with The...More
The Hebrew University is the only Israeli institution participating in ncRNAPain, a new European research project exploring the biological...More
Hebrew University pioneer in computational neuroscience Prof. Haim... More
“It is no exaggeration to say the brain drain is jeopardizing everything...More
The Canadian premiere screening of ‘Jerusalem’ in Ottawa was hosted by the Hebrew Univeristy's Canadian Friends...More